ロード中...
Energy Regulation Mechanism and Therapeutic Potential of Asprosin
Genetic studies of patients with neonatal progeroid syndrome led to the discovery of the novel fasting-induced, glucogenic, and orexigenic hormone named asprosin, the C-terminal cleavage product of profibrillin. Upon secretion, asprosin travels to the liver, where it exerts a glucogenic effect throu...
保存先:
| 出版年: | Diabetes |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Diabetes Association
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7085243/ https://ncbi.nlm.nih.gov/pubmed/32198197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dbi19-0009 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|